OCEL Insider Trading Activity and SEC Form 4 Filings
OCEL insider trading summary
No open-market insider purchases or sales of Organicell Regenerative Medicine, Inc. (OCEL) have been reported on SEC Form 4 in the past 12 months.
Latest OCEL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 19, 2023 | Harry L. Leider | Chief Executive Officer | Sell | $7K (5,248 @ $1.31) |
| Jul 7, 2023 | Skycrest Holdings, LLC | 10% Owner | Buy | $3K (320,710 @ $0.01) |
| Jun 29, 2023 | Harry L. Leider | Chief Executive Officer | Buy | $5K (500,000 @ $0.01) |
| Jun 29, 2023 | Skycrest Holdings, LLC | 10% Owner | Buy | $2K (200,000 @ $0.01) |
| Jun 28, 2023 | Harry L. Leider | Chief Executive Officer | Buy | $54K (549,450 @ $0.10) |
| Jun 28, 2023 | Skycrest Holdings, LLC | 10% Owner | Buy | $4K (400,000 @ $0.01) |
| Jun 26, 2023 | Skycrest Holdings, LLC | 10% Owner | Buy | $7K (800,000 @ $0.01) |
| Oct 13, 2022 | Matthew Phillip Sinnreich | President and Acting CEO | Sell | $800 (20,000 @ $0.04) |
| Feb 9, 2015 | Ricardo Prats | President, CEO, CFO, Treasurer | Sell | $600 (5,000 @ $0.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.